Tanja N. Fehm - Publications

Clinical Relevance of Post-Treatment Circulating Tumor DNA Detection in Early Breast Cancer Using a Tissue-Free Epigenomic Assay: A 2-Year Landmark Analysis.

Journal: JCO precision oncology

Published: September 04, 2026

Real-world insights into bone marrow carcinomatosis in metastatic breast cancer: a retrospective analysis from two large university breast cancer centers.

Journal: Journal of cancer research and clinical oncology

Published: May 09, 2026

AGO Breast Panel Recommendations for the use of treatment-relevant biomarkers in early and advanced breast cancer-2026 Update.

Journal: Breast (Edinburgh, Scotland)

Published: April 29, 2026

Spectrum of double heterozygosity in individuals diagnosed with hereditary breast and ovarian cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 24, 2026

AGO Breast Committee recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2026.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: March 24, 2026

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2026.

Journal: Breast care (Basel, Switzerland)

Published: March 08, 2026

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2026.

Journal: Breast care (Basel, Switzerland)

Published: March 05, 2026

Statement by the Uterus Commission of the Arbeitsgemeinschaft Gynäkologische Onkologie [German Gynecological Oncology Group] (AGO) on the ESGO-ESTRO-ESP Guideline 2025.

Journal: Geburtshilfe und Frauenheilkunde

Published: February 03, 2026

Genetic Testing and Imaging in Men with Familial History or Genetic Predisposition of Prostate Cancer-Introducing the Prospective "ProFam-Risk" Study.

Journal: European urology open science

Published: December 23, 2025

Feasibility of a virtual reality (VR)-supported mindfulness intervention for patients with cancer during chemotherapy

Journal: Psychotherapie, Psychosomatik, medizinische Psychologie

Published: December 15, 2025

Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 03, 2025

PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer-Results from the prospective PRAEGNANT registry.

Journal: NPJ breast cancer

Published: November 29, 2025